Similar articles for PMID: 19399906

Year	Number of Results
1898	1
1983	1
2005	3
2006	6
2007	9
2008	30
2009	40
2010	3
2011	5
2012	5
2013	3
2014	1
2015	1
2016	2
2017	2
2018	2
2019	2
2020	4
2021	4
2022	3
2024	0

1

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma.

Wülfing C, Machiels JP, Richel DJ, Grimm MO, Treiber U, De Groot MR, Beuzeboc P, Parikh R, Pétavy F, El-Hariry IA. Wülfing C, et al. Cancer. 2009 Jul 1;115(13):2881-90. doi: 10.1002/cncr.24337. Cancer. 2009. PMID: 19399906 Free article. Clinical Trial.

2

Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.

Ravaud A, Hawkins R, Gardner JP, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Machiels JP, Pétavy F, Gore M, Schöffski P, El-Hariry I. Ravaud A, et al. J Clin Oncol. 2008 May 10;26(14):2285-91. doi: 10.1200/JCO.2007.14.5029. J Clin Oncol. 2008. PMID: 18467719 Clinical Trial.

3

Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.

Johnston S, Trudeau M, Kaufman B, Boussen H, Blackwell K, LoRusso P, Lombardi DP, Ben Ahmed S, Citrin DL, DeSilvio ML, Harris J, Westlund RE, Salazar V, Zaks TZ, Spector NL. Johnston S, et al. J Clin Oncol. 2008 Mar 1;26(7):1066-72. doi: 10.1200/JCO.2007.13.9949. Epub 2008 Jan 22. J Clin Oncol. 2008. PMID: 18212337 Clinical Trial.

4

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

Medina PJ, Goodin S. Medina PJ, et al. Clin Ther. 2008 Aug;30(8):1426-47. doi: 10.1016/j.clinthera.2008.08.008. Clin Ther. 2008. PMID: 18803986 Review.

5

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

Sweeney CJ, Roth BJ, Kabbinavar FF, Vaughn DJ, Arning M, Curiel RE, Obasaju CK, Wang Y, Nicol SJ, Kaufman DS. Sweeney CJ, et al. J Clin Oncol. 2006 Jul 20;24(21):3451-7. doi: 10.1200/JCO.2005.03.6699. J Clin Oncol. 2006. PMID: 16849761 Clinical Trial.

6

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.

Kouno T, Ando M, Yonemori K, Matsumoto K, Shimizu C, Katsumata N, Komiyama M, Okajima E, Matsuoka N, Fujimoto H, Fujiwara Y. Kouno T, et al. Eur Urol. 2007 Oct;52(4):1115-22. doi: 10.1016/j.eururo.2007.03.078. Epub 2007 Apr 5. Eur Urol. 2007. PMID: 17433855 Clinical Trial.

7

Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.

Schiller JH, Larson T, Ou SH, Limentani S, Sandler A, Vokes E, Kim S, Liau K, Bycott P, Olszanski AJ, von Pawel J. Schiller JH, et al. J Clin Oncol. 2009 Aug 10;27(23):3836-41. doi: 10.1200/JCO.2008.20.8355. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597027 Clinical Trial.

8

Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.

Monk BJ, Mas Lopez L, Zarba JJ, Oaknin A, Tarpin C, Termrungruanglert W, Alber JA, Ding J, Stutts MW, Pandite LN. Monk BJ, et al. J Clin Oncol. 2010 Aug 1;28(22):3562-9. doi: 10.1200/JCO.2009.26.9571. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606083 Clinical Trial.

9

Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.

Boussen H, Cristofanilli M, Zaks T, DeSilvio M, Salazar V, Spector N. Boussen H, et al. J Clin Oncol. 2010 Jul 10;28(20):3248-55. doi: 10.1200/JCO.2009.21.8594. Epub 2010 Jun 7. J Clin Oncol. 2010. PMID: 20530274 Clinical Trial.

10

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.

Gomez HL, Doval DC, Chavez MA, Ang PC, Aziz Z, Nag S, Ng C, Franco SX, Chow LW, Arbushites MC, Casey MA, Berger MS, Stein SH, Sledge GW. Gomez HL, et al. J Clin Oncol. 2008 Jun 20;26(18):2999-3005. doi: 10.1200/JCO.2007.14.0590. Epub 2008 May 5. J Clin Oncol. 2008. PMID: 18458039 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

114 results

Results by year